CNC Stock Cash Flow Statements

Centene Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Centene Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31

cash flows from operating activities:
net earnings	-259,000,000	1,314,000,000	280,000,000	710,000,000	1,146,000,000	1,158,000,000	39,000,000	475,000,000	1,055,000,000	1,130,000,000	-219,000,000	740,000,000	-171,000,000	852,000,000	593,000,000	581,000,000	-535,000,000	697,000,000	-19,000,000	565,000,000	1,202,000,000	46,000,000	202,000,000	96,000,000	492,000,000	519,000,000	241,000,000	16,000,000	299,000,000	338,000,000	223,000,000	201,000,000	252,000,000	132,000,000	263,000,000	146,000,000	168,000,000	-16,000,000	111,000,000	94,000,000	88,000,000	64,000,000	104,376,000	79,151,000	48,126,000	32,347,000	54,882,000	48,914,000	39,011,000	22,911,000	4,639,000	295,000	-38,832,000	22,603,000	29,264,000	28,213,000	28,063,000	22,823,000	26,319,000	23,200,000	24,502,000	24,250,000
adjustments to reconcile net earnings to net cash from operating activities
depreciation and amortization	315,000,000	314,000,000	314,000,000	313,000,000	306,000,000	308,000,000	315,000,000	328,000,000	304,000,000	346,000,000	375,000,000	391,000,000	397,000,000	390,000,000	378,000,000	381,000,000	356,000,000	361,000,000	343,000,000	298,000,000	330,000,000	288,000,000	168,000,000	162,000,000	158,000,000	155,000,000	141,000,000	139,000,000	111,000,000	104,000,000	97,000,000	91,000,000	87,000,000	86,000,000	89,000,000	78,000,000	76,000,000	35,000,000	29,000,000	29,000,000	26,000,000	27,000,000	23,992,000	22,907,000	21,783,000	20,318,000	17,200,000	17,292,000	17,237,000	15,691,000	15,974,000	16,626,000	16,653,000	16,613,000	15,272,000	14,488,000	14,242,000	14,325,000	13,380,000	13,702,000	12,391,000	12,527,000
stock compensation expense	35,000,000	59,000,000	31,000,000	49,000,000	62,000,000	70,000,000	49,000,000	50,000,000	56,000,000	61,000,000	54,000,000	51,000,000	59,000,000	70,000,000	76,000,000	40,000,000	36,000,000	51,000,000	63,000,000	54,000,000	47,000,000	117,000,000	71,000,000	34,000,000	34,000,000	38,000,000	40,000,000	38,000,000	34,000,000	33,000,000	36,000,000	37,000,000	30,000,000	32,000,000	36,000,000	29,000,000	32,000,000	51,000,000	23,000,000	15,000,000	17,000,000	16,000,000	13,387,000	11,863,000	11,453,000	11,297,000	9,404,000	10,297,000	8,580,000	8,375,000	6,915,000	6,424,000	5,618,000	6,375,000	4,908,000	4,424,000	4,445,000	4,394,000	3,650,000	3,336,000	3,428,000	3,460,000
impairment			0	0	0	13,000,000	51,000,000	440,000,000	18,000,000	20,000,000	579,000,000	289,000,000			0				0	0	0	72,000,000
deferred income taxes	-89,000,000	-27,000,000	-1,000,000	-26,000,000	-64,000,000	104,000,000	-92,000,000	174,000,000	-1,000,000	-159,000,000	51,000,000	-265,000,000	-429,000,000	12,000,000	11,000,000	-67,000,000	-232,000,000	156,000,000	103,000,000	-171,000,000	-95,000,000	112,000,000	130,000,000	-65,000,000	-33,000,000	23,000,000	-26,000,000	-107,000,000	-26,000,000	30,000,000	-76,000,000	26,000,000	-7,000,000	-51,000,000	109,000,000	-4,000,000	4,000,000	-17,000,000	-3,000,000	-1,000,000	-7,000,000	-6,000,000	22,931,000	-53,673,000	-3,385,000	-7,873,000	-3,919,000	-9,089,000	9,729,000	986,000	4,880,000	-28,682,000	3,509,000	5,855,000	2,254,000	3,306,000	-2,829,000	-700,000	3,305,000	2,084,000	3,978,000	950,000
(gain) loss on divestitures	0	10,000,000	-17,000,000	0	-5,000,000	-98,000,000	20,000,000
other adjustments	11,000,000	5,000,000	18,000,000	9,000,000	-9,000,000	-2,000,000	14,000,000	90,000,000	61,000,000	7,000,000	-195,000,000	2,000,000	140,000,000	22,000,000	-5,000,000	-20,000,000	12,000,000	2,000,000			-22,000,000	24,000,000
changes in assets and liabilities
premium and trade receivables	883,000,000	-2,684,000,000	-1,596,000,000	-1,678,000,000	152,000,000	-1,211,000,000	-51,000,000	-2,010,000,000	1,619,000,000	-1,938,000,000	-353,000,000	14,000,000	1,811,000,000	-3,099,000,000	-730,000,000	-209,000,000	377,000,000	-1,891,000,000	1,588,000,000	-481,000,000	1,023,000,000	-2,182,000,000	-757,000,000	-553,000,000	896,000,000	-662,000,000	-477,000,000	-143,000,000	-377,000,000	-176,000,000
other assets	126,000,000	-669,000,000	-32,000,000	482,000,000	70,000,000	-474,000,000	108,000,000	222,000,000	-10,000,000	-315,000,000	-24,000,000	397,000,000	54,000,000	-299,000,000	25,000,000	334,000,000	-171,000,000	-287,000,000	-215,000,000	-17,000,000	105,000,000	97,000,000	-220,000,000	33,000,000	-67,000,000	20,000,000	-103,000,000	63,000,000	-49,000,000	51,000,000	-107,000,000	-104,000,000	-24,000,000	89,000,000					31,000,000	-10,000,000	-17,000,000	-13,000,000	43,625,000	-22,892,000	-14,308,000	-14,425,000	64,661,000	-27,206,000	-38,196,000	5,000	907,000	398,000	996,000	524,000	1,228,000	-352,000	-1,029,000	151,000	-1,038,000	-2,709,000	-218,000	1,937,000
medical claims liabilities	206,000,000	1,603,000,000	373,000,000	-178,000,000	65,000,000	108,000,000	860,000,000	262,000,000	-620,000,000	759,000,000	421,000,000	-113,000,000	322,000,000	1,767,000,000	141,000,000	1,336,000,000	-80,000,000	405,000,000	-446,000,000	1,417,000,000	-106,000,000	252,000,000	-513,000,000	533,000,000	10,000,000	548,000,000	-55,000,000	663,000,000	232,000,000	485,000,000	-47,000,000	163,000,000	-115,000,000	358,000,000	130,000,000	-173,000,000	-8,000,000	196,000,000	142,000,000	28,000,000	139,000,000	227,000,000	132,586,000	192,280,000	87,913,000	196,221,000	67,674,000	-7,730,000	-5,760,000	117,385,000	-14,254,000	122,996,000	150,281,000	100,769,000		15,792,000	11,254,000	13,430,000		-436,000	4,261,000	-33,129,000
unearned revenue	-187,000,000	208,000,000	4,000,000	60,000,000	-84,000,000	-34,000,000	-1,640,000,000	-17,000,000	-24,000,000	1,919,000,000	-1,933,000,000	1,889,000,000	-6,000,000	81,000,000	60,000,000	-86,000,000	-131,000,000	48,000,000	-316,000,000	-85,000,000	-39,000,000	-88,000,000	1,000,000	128,000,000	-116,000,000	-22,000,000	98,000,000	-352,000,000	-115,000,000	317,000,000	-236,000,000	14,000,000	-79,000,000	320,000,000	-258,000,000	351,000,000	14,000,000	-64,000,000	77,000,000	-2,000,000	-51,000,000	-51,000,000	75,000,000	72,066,000	-52,728,000	34,662,000	-5,252,000	20,044,000	-15,646,000	3,578,000	-97,370,000	102,192,000	11,309,000	8,576,000	-43,899,000	-52,718,000	-22,571,000	10,106,000	64,408,000	47,242,000	-12,668,000	-73,282,000
accounts payable and accrued expenses	-354,000,000	563,000,000	-25,000,000	1,201,000,000	-293,000,000	-1,411,000,000	271,000,000	2,509,000,000	-930,000,000	1,548,000,000	-265,000,000	645,000,000	-916,000,000	957,000,000	148,000,000	-292,000,000	1,253,000,000	32,000,000	1,446,000,000	-2,170,000,000	605,000,000	704,000,000	131,000,000	64,000,000	-973,000,000	357,000,000	-568,000,000	900,000,000	-1,022,000,000	157,000,000	-152,000,000	462,000,000	-20,000,000	-237,000,000	303,000,000	107,000,000	-43,000,000	35,000,000	-170,000,000	43,000,000	108,000,000	58,000,000	78,872,000	267,000,000	69,647,000	90,481,000	102,872,000	50,328,000	21,257,000	-22,745,000	38,398,000	17,138,000	-16,184,000	-60,826,000	50,303,000	23,325,000	-61,007,000	26,268,000	40,572,000	362,000	-43,969,000	40,433,000
other long-term liabilities	1,043,000,000	814,000,000	14,000,000	-1,922,000,000	825,000,000	1,013,000,000	273,000,000	-1,498,000,000	1,111,000,000	970,000,000	-21,000,000	-195,000,000	657,000,000	401,000,000	129,000,000	-197,000,000	738,000,000	423,000,000	415,000,000	-365,000,000	667,000,000	361,000,000	117,000,000	-801,000,000	522,000,000	347,000,000	59,000,000	-666,000,000	388,000,000	477,000,000	23,000,000	-736,000,000	322,000,000	459,000,000
other operating activities			50,000,000	2,000,000			0				1,000,000	0			-1,000,000				6,000,000	5,000,000	8,000,000	6,000,000	-11,000,000	-1,000,000	-6,000,000	-7,000,000	16,000,000	-3,000,000	-1,000,000	30,000,000			3,000,000	1,000,000	-77,000,000	94,000,000	4,000,000	-7,000,000	1,000,000	2,000,000	3,000,000	2,000,000	74,787,000	8,965,000	7,035,000	5,213,000	8,179,000	-1,508,000	1,572,000	4,078,000	1,819,000	-4,814,000	-3,844,000	-1,078,000	6,632,000	-27,000	2,823,000	732,000	694,000	-3,118,000	-83,000	1,934,000
net cash from operating activities	1,785,000,000	1,510,000,000	-587,000,000	-978,000,000	2,175,000,000	-456,000,000	217,000,000	1,021,000,000	2,546,000,000	4,269,000,000	-1,576,000,000	3,332,000,000	3,354,000,000	1,151,000,000	675,000,000	1,802,000,000	1,685,000,000	43,000,000	2,981,000,000	-952,000,000	3,714,000,000	-240,000,000	-651,000,000	-99,000,000	917,000,000	1,316,000,000	-634,000,000	548,000,000	-526,000,000	1,846,000,000	450,000,000	97,000,000	-306,000,000	1,248,000,000	1,596,000,000	480,000,000	-420,000,000	195,000,000	201,000,000	62,000,000	350,000,000	45,000,000	369,266,000	441,845,000	159,444,000	252,445,000	170,856,000	130,731,000	37,946,000	42,993,000	-28,591,000	317,182,000	22,196,000	-32,096,000	172,023,000	36,519,000	-40,837,000	93,991,000	194,625,000	72,563,000	-59,756,000	-38,500,000
cash flows from investing activities:
capital expenditures	-208,000,000	-135,000,000	-154,000,000	-153,000,000	-186,000,000	-151,000,000	-223,000,000	-136,000,000	-215,000,000	-225,000,000	-233,000,000	-247,000,000	-282,000,000	-242,000,000	-248,000,000	-225,000,000	-250,000,000	-187,000,000	-206,000,000	-251,000,000	-235,000,000	-177,000,000	-200,000,000	-194,000,000	-160,000,000	-176,000,000	-186,000,000	-127,000,000	-144,000,000	-218,000,000	-121,000,000	-120,000,000	-98,000,000	-83,000,000	-95,000,000	-117,000,000	-49,000,000	-45,000,000	-49,000,000	-43,000,000	-31,000,000	-27,000,000	-34,472,000	-26,960,000	-23,452,000	-18,116,000	-21,452,000	-16,326,000	-19,403,000	-10,654,000	-11,543,000	-13,159,000	-42,462,000	-14,980,000	-16,062,000	-21,187,000	-16,019,000	-15,725,000	28,656,000	-28,358,000	-40,503,000	-23,099,000
free cash flows	1,577,000,000	1,375,000,000	-741,000,000	-1,131,000,000	1,989,000,000	-607,000,000	-6,000,000	885,000,000	2,331,000,000	4,044,000,000	-1,809,000,000	3,085,000,000	3,072,000,000	909,000,000	427,000,000	1,577,000,000	1,435,000,000	-144,000,000	2,775,000,000	-1,203,000,000	3,479,000,000	-417,000,000	-851,000,000	-293,000,000	757,000,000	1,140,000,000	-820,000,000	421,000,000	-670,000,000	1,628,000,000	329,000,000	-23,000,000	-404,000,000	1,165,000,000	1,501,000,000	363,000,000	-469,000,000	150,000,000	152,000,000	19,000,000	319,000,000	18,000,000	334,794,000	414,885,000	135,992,000	234,329,000	149,404,000	114,405,000	18,543,000	32,339,000	-40,134,000	304,023,000	-20,266,000	-47,076,000	155,961,000	15,332,000	-56,856,000	78,266,000	223,281,000	44,205,000	-100,259,000	-61,599,000
purchases of investments	-1,963,000,000	-1,630,000,000	-1,413,000,000	-2,336,000,000	-2,117,000,000	-1,317,000,000	-1,893,000,000	-1,530,000,000	-1,580,000,000	-1,619,000,000	-1,618,000,000	-2,004,000,000	-1,414,000,000	-1,700,000,000	-2,147,000,000	-1,663,000,000	-1,937,000,000	-1,653,000,000	-4,491,000,000	-1,062,000,000	-449,000,000	-1,400,000,000	-501,000,000	-794,000,000	-700,000,000	-580,000,000	-1,155,000,000	-1,316,000,000	-610,000,000	-765,000,000	-984,000,000	-426,000,000	-700,000,000	-594,000,000	-922,000,000	-572,000,000	-744,000,000	-212,000,000	-244,000,000	-564,000,000	-206,000,000	-307,000,000	-276,526,000	-263,127,000	-307,974,000	-167,373,000	-124,637,000	-128,426,000	-179,459,000	-358,131,000	-193,729,000	-95,057,000	-151,689,000	-255,212,000		-97,906,000	-62,816,000	-40,423,000		-76,606,000	-159,189,000	-146,935,000
sales and maturities of investments	1,272,000,000	1,236,000,000	1,638,000,000	1,650,000,000	1,056,000,000	1,441,000,000	1,150,000,000	2,080,000,000	1,145,000,000	1,148,000,000	960,000,000	837,000,000	958,000,000	1,047,000,000	1,389,000,000	1,260,000,000	1,418,000,000	1,391,000,000	1,513,000,000	1,640,000,000	866,000,000	902,000,000	562,000,000	528,000,000	336,000,000	383,000,000	416,000,000	854,000,000	276,000,000	445,000,000	564,000,000	345,000,000	641,000,000	349,000,000	701,000,000	362,000,000	390,000,000	203,000,000	251,000,000	142,000,000	165,000,000	111,000,000	86,289,000	98,369,000	109,348,000	111,994,000	128,127,000	92,063,000	146,463,000	212,508,000	155,912,000	180,290,000	104,378,000	149,341,000	87,280,000	59,676,000	75,121,000	45,327,000	118,295,000	160,393,000	174,266,000	117,469,000
divestiture proceeds, net of divested cash			31,000,000	0	80,000,000	879,000,000	17,000,000	21,000,000	226,000,000	443,000,000	1,115,000,000					0			0	0	10,000,000	456,000,000
net cash (used in) investing activities							-949,000,000	435,000,000	-424,000,000	-253,000,000
cash flows from financing activities:
proceeds from long-term debt	0	750,000,000	950,000,000	0	0	350,000,000	165,000,000	889,000,000	994,000,000	287,000,000	3,000,000	26,000,000	231,000,000	100,000,000	20,000,000	6,849,000,000	81,000,000	2,317,000,000	2,420,000,000	57,000,000	88,000,000	2,542,000,000	12,265,000,000	6,839,000,000	4,599,000,000	1,018,000,000		334,000,000	3,131,000,000	2,015,000,000		360,000,000	250,000,000	560,000,000
payments and repurchases of long-term debt	-749,000,000	-958,000,000	-28,000,000	-29,000,000	-378,000,000	-187,000,000	-346,000,000	-648,000,000			-288,000,000
common stock repurchases	-432,000,000	-41,000,000	-943,000,000	-1,227,000,000	-803,000,000	-151,000,000	-31,000,000	-774,000,000	-405,000,000	-423,000,000	-1,433,000,000	-1,243,000,000	-349,000,000	-71,000,000	-248,000,000	-16,000,000	-4,000,000	-29,000,000	-56,000,000	-9,000,000	-3,000,000	-558,000,000	-34,000,000	-4,000,000	-2,000,000	-35,000,000	-54,000,000	-4,000,000	-4,000,000	-9,000,000	-47,000,000	-3,000,000	-2,000,000	-13,000,000	-34,000,000	-2,000,000	-5,000,000	-22,000,000	-44,000,000	-2,000,000	-3,000,000	-4,000,000	-23,368,000	-763,000	-2,857,000	-2,012,000	-14,102,000	-4,572,000	-540,000	-565,000	-10,587,000	-363,000	-282,000	-1,509,000	-6,529,000	-251,000	-627,000	-402,000	-2,510,000	-146,000	-88,000	-480,000
proceeds from common stock issuances	8,000,000	10,000,000	9,000,000	12,000,000	11,000,000	14,000,000	12,000,000	11,000,000
other financing activities	-1,000,000	-11,000,000	-1,000,000	-1,000,000	-1,000,000	-3,000,000				11,000,000	-84,000,000	25,000,000	6,000,000	26,000,000	16,000,000	15,000,000	9,000,000	15,000,000	12,000,000	13,000,000	15,000,000	7,000,000	4,000,000	3,000,000	7,000,000	2,000,000	11,000,000	-1,000,000	1,000,000	-2,000,000	3,000,000	-4,000,000	3,000,000	3,000,000	-15,000,000	-6,000,000	5,000,000	2,000,000
net cash (used in) financing activities								-524,000,000	-750,000,000	-183,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash			1,000,000	0	1,000,000	6,000,000																		2,000,000
net increase in cash, cash equivalents and restricted cash and cash equivalents	-288,000,000	731,000,000	-497,000,000	-3,062,000,000	-162,000,000	425,000,000									-420,000,000	2,439,000,000				-611,000,000				-664,000,000	541,000,000	1,001,000,000
cash, cash equivalents and restricted cash and cash equivalents, beginning of period	0	14,156,000,000	0	0	0	17,452,000,000
cash, cash equivalents and restricted cash and cash equivalents, end of period	-288,000,000	14,887,000,000	-494,000,000	-3,065,000,000	-162,000,000	17,877,000,000
supplemental disclosures of cash flow information:
interest paid	191,000,000	129,000,000	193,000,000	143,000,000	197,000,000	155,000,000	192,000,000	148,000,000	204,000,000	144,000,000	195,000,000	135,000,000	188,000,000	139,000,000	179,000,000	124,000,000	225,000,000	130,000,000	246,000,000	119,000,000	256,000,000	104,000,000	161,000,000	81,000,000	45,000,000	87,000,000	110,000,000	83,000,000	57,000,000	73,000,000	27,000,000	111,000,000	27,000,000	72,000,000	52,000,000	77,000,000	33,000,000	3,000,000	27,000,000	1,000,000	25,000,000	2,000,000	22,098,000	1,463,000	14,791,000	1,648,000	13,271,000	1,568,000	13,760,000	1,410,000	9,478,000	1,815,000	8,723,000	1,589,000	11,286,000	4,275,000	10,108,000	1,714,000	7,795,000	2,181,000	6,975,000	345,000
income taxes paid	497,000,000	7,000,000	181,000,000	211,000,000	597,000,000	13,000,000	124,000,000	167,000,000	581,000,000	11,000,000	774,000,000	37,000,000	400,000,000	11,000,000	201,000,000	71,000,000	386,000,000	20,000,000	271,000,000	845,000,000	72,000,000	3,000,000	101,000,000	130,000,000	375,000,000	6,000,000	108,000,000	145,000,000	194,000,000	1,000,000	138,000,000	153,000,000	203,000,000	2,000,000	162,000,000	172,000,000	189,000,000	33,000,000	99,000,000	84,000,000	121,000,000	24,000,000	69,717,000	57,165,000	88,853,000	21,265,000	43,760,000	19,227,000	19,489,000	2,205,000	8,876,000	1,607,000	11,880,000	20,514,000	448,000	9,885,000	30,544,000	9,567,000	9,531,000	16,467,000	19,668,000	8,272,000
the following table provides a reconciliation of cash, cash equivalents and restricted cash and cash equivalents reported within the consolidated balance sheets to the totals above:
cash and cash equivalents	-302,000,000	14,815,000,000	-514,000,000	-3,028,000,000	20,000,000	17,585,000,000	-997,000,000	1,020,000,000	1,317,000,000	15,853,000,000	-2,913,000,000	1,552,000,000	2,198,000,000	11,237,000,000	-305,000,000	2,405,000,000	1,391,000,000	9,627,000,000	-1,398,000,000	-600,000,000	3,490,000,000	9,308,000,000		-660,000,000	530,000,000	6,345,000,000
restricted cash and cash equivalents, included in restricted deposits	14,000,000	72,000,000	20,000,000	-37,000,000	-182,000,000	292,000,000	-1,000,000	-98,000,000	46,000,000	312,000,000	28,000,000	82,000,000	-116,000,000	262,000,000	-115,000,000	34,000,000	-500,000,000	677,000,000	11,000,000	-11,000,000	8,000,000	149,000,000		-4,000,000	11,000,000	6,000,000
total cash, cash equivalents and restricted cash and cash equivalents	-288,000,000	14,887,000,000		-3,065,000,000	-162,000,000	17,877,000,000
net cash from investing activities		-529,000,000	102,000,000	-839,000,000	-1,167,000,000	852,000,000						3,000,000	-744,000,000	-2,401,000,000	-857,000,000	-1,022,000,000	-813,000,000	-607,000,000	-4,255,000,000	332,000,000	240,000,000	-3,272,000,000	-144,000,000	-459,000,000	-556,000,000	-373,000,000	-1,022,000,000	-2,310,000,000	-489,000,000	-764,000,000	-579,000,000	-200,000,000	-157,000,000	-329,000,000	-765,000,000	-313,000,000	-483,000,000	-836,000,000	-44,000,000	-470,000,000	-74,000,000	-225,000,000	-266,555,000	-191,868,000	-239,093,000	-150,484,000	-17,962,000	-48,630,000	-119,231,000	-156,277,000	-49,360,000	72,074,000	-89,773,000	-120,851,000	-47,925,000	-60,040,000	-9,133,000	-11,978,000	-174,618,000	50,055,000	-44,880,000	-41,164,000
net cash from financing activities		-250,000,000	-13,000,000	-1,245,000,000	-1,171,000,000	23,000,000					-1,732,000,000	-1,481,000,000	-486,000,000	-498,000,000	-235,000,000	1,643,000,000	27,000,000	-73,000,000	-123,000,000	4,000,000	-460,000,000	839,000,000	6,704,000,000	-108,000,000	178,000,000	58,000,000	152,000,000	82,000,000	3,865,000,000	513,000,000	-79,000,000	-42,000,000	49,000,000	-10,000,000	119,000,000	104,000,000	177,000,000	2,317,000,000	-62,000,000	106,000,000	25,000,000	236,000,000	-75,099,000	74,687,000	67,654,000	130,758,000	143,898,000	-29,532,000	39,206,000	123,000	125,282,000	-14,529,000	56,473,000	12,247,000	-2,057,000	728,000	32,375,000	-24,134,000	16,493,000	9,448,000	20,147,000	26,001,000
(gain) loss on debt extinguishment											1,000,000	-10,000,000	-13,000,000	-3,000,000
(gain) on acquisition											0
loss on disposal of equipment
acquisitions, net of cash acquired											-3,000,000	55,000,000	-8,000,000	-1,504,000,000	0	-394,000,000	18,000,000	-158,000,000	-1,049,000,000	0	48,000,000	-3,048,000,000	-5,000,000	1,000,000				-1,721,000,000	-11,000,000	-226,000,000
payments for debt extinguishment											0	13,000,000	0	-27,000,000	0	-103,000,000	0	-54,000,000	-60,000,000	0	0	-21,000,000
purchase of noncontrolling interest							-1,000,000	-2,000,000	-27,000,000	-58,000,000																	-11,000,000	0			-33,000,000					0	0	-14,000,000
cash and cash equivalents reclassified (to) from held for sale
equity issued in connection with acquisitions																			0	0	0	11,526,000,000					0	0	183,000,000	324,000,000					0	0	0	3,105,000,000	0	-1,000,000	0	13,000,000
total cash, cash equivalents, and restricted cash and cash equivalents							-998,000,000	922,000,000	1,363,000,000	16,165,000,000	-2,885,000,000	1,634,000,000	2,082,000,000	11,499,000,000	-420,000,000	2,439,000,000	891,000,000	10,304,000,000	-1,387,000,000	-611,000,000	3,498,000,000	9,457,000,000		-664,000,000	541,000,000	6,351,000,000
other investing activities														-2,000,000							0	-5,000,000											0	-1,000,000
debt issuance costs															0	-44,000,000	-1,000,000	-27,000,000	-26,000,000	-1,000,000	-1,000,000	-92,000,000	-19,000,000				0
effect of exchange rate changes on cash, cash equivalents, and restricted cash								26,000,000	-9,000,000	2,000,000	26,000,000	-28,000,000	-42,000,000	33,000,000	-3,000,000	16,000,000	-8,000,000	-16,000,000	10,000,000	5,000,000	4,000,000	-1,000,000
net increase in cash, cash equivalents, and restricted cash and cash equivalents								958,000,000	1,363,000,000	3,835,000,000	-3,061,000,000
cash and cash equivalents reclassified from (to) held for sale
cash, cash equivalents, and restricted cash and cash equivalents, beginning of period								0	0	12,330,000,000	0	0	0	13,214,000,000	0	0	0	10,957,000,000	0	0	0	12,131,000,000	0	0	0	5,350,000,000	0	0	0	4,089,000,000
cash, cash equivalents, and restricted cash and cash equivalents, end of period								922,000,000	1,363,000,000	16,165,000,000	-2,885,000,000	1,634,000,000	2,082,000,000	11,499,000,000	-420,000,000	2,439,000,000	891,000,000	10,304,000,000	-1,387,000,000	-611,000,000	3,498,000,000	9,457,000,000	5,903,000,000	-664,000,000	541,000,000	6,351,000,000	-1,504,000,000	-1,680,000,000	2,850,000,000	5,684,000,000
the following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the consolidated balance sheets to the totals above:
(gain) on divestiture									-93,000,000	-79,000,000
(gain) on divestitures
gain on acquisition															0
gain on divestiture																0			0	0	-11,000,000	-93,000,000
payments of long-term debt													-374,000,000	-526,000,000	-23,000,000	-5,058,000,000	-58,000,000	-2,295,000,000	-2,413,000,000	-56,000,000	-559,000,000	-1,039,000,000	-5,510,000,000	-6,940,000,000	-4,426,000,000	-927,000,000		-221,000,000	-1,980,000,000	-1,491,000,000		-362,000,000	-202,000,000	-560,000,000
net decrease in cash, cash equivalents and restricted cash and cash equivalents														-1,715,000,000				-653,000,000
loss on debt extinguishment															0	79,000,000	0	46,000,000	13,000,000	0	0	44,000,000
gain on divestitures
divestiture proceeds
proceeds from the issuance of common stock																											0	-1,000,000
net increase in cash, cash equivalents, and restricted cash and equivalents
net increase																						-2,674,000,000
goodwill and intangible impairment																							0
contribution from noncontrolling interest																																							9,000,000				593,000	0	0	5,407,000	2,204,000	1,944,000	3,718,000	202,000		50,000							0	0	0	306,000
debt extinguishment costs																																																							0	0
investments in acquisitions, net of cash acquired																																			-449,000,000	14,000,000	-80,000,000	-782,000,000	-2,000,000	-5,000,000	-2,000,000	-9,000,000	-41,846,000	-150,000	-17,015,000	-76,989,000	0	4,059,000								0				-5,374,000	-19,454,000	-2,019,000
proceeds from borrowings																																			1,990,000,000	1,245,000,000	1,921,000,000	3,790,000,000	620,000,000	555,000,000	250,000,000	500,000,000	490,000,000	240,000,000	500,000,000	645,000,000	150,000,000	0			185,500,000	140,000,000			0	0	291,883,000	127,300,000	164,726,000	11,651,000	20,131,000	22,030,000
payment of long-term debt																																												-171,684,000	-426,479,000	-519,413,000		-30,724,000	-9,342,000	-776,000	-40,812,000	-155,821,000	-20,806,000	-795,000	-808,000	-780,000	-262,118,000	-152,577,000	-98,261,000	-274,000	-57,000	-97,136,000
net increase in cash, cash equivalents and restricted cash																											-1,504,000,000	-1,680,000,000	2,850,000,000	1,595,000,000
gain on contingent consideration																																			-3,000,000	-1,000,000	0	-1,000,000
goodwill and intangible adjustment																																							10,000,000
effect of exchange rate changes on cash and cash equivalents																																			-2,000,000								-511,000
net increase in cash and cash equivalents																															-209,000,000	-144,000,000	-414,000,000	909,000,000	948,000,000	272,000,000	-726,000,000	1,676,000,000	95,000,000	-302,000,000	301,000,000	56,000,000	27,101,000	324,175,000	-11,995,000	232,719,000	296,792,000				47,331,000	374,727,000	-11,104,000	-140,700,000	122,041,000	-22,793,000	-17,595,000	57,879,000	36,500,000	132,066,000
cash and cash equivalents, beginning of period																															0	0	0	3,930,000,000	0	0	0	1,760,000,000	0	0	0	1,610,000,000	-73,000	0	0	1,038,073,000	0	0	0	843,952,000	0	0	0	573,698,000	0	0	0	434,166,000	0	0	0	403,752,000
cash and cash equivalents, end of period																															-209,000,000	-144,000,000	-414,000,000	4,839,000,000	948,000,000	272,000,000	-726,000,000	3,436,000,000	95,000,000	-302,000,000	301,000,000	1,666,000,000	27,028,000	324,175,000	-11,995,000	1,270,792,000	296,792,000	52,569,000	-42,079,000	730,791,000	47,331,000	374,727,000	-11,104,000	432,998,000	122,041,000	-22,793,000	-17,595,000	492,045,000	36,500,000	132,066,000	-84,489,000	350,089,000
premium and related receivables																																-53,000,000	-755,000,000	59,000,000	980,000,000	215,000,000	-947,000,000	-174,000,000	0	-19,000,000	-7,000,000	-334,000,000	-219,968,000	-82,318,000	-41,507,000	-119,207,000	-84,390,000	12,643,000	-14,496,000	-56,734,000	22,856,000	93,331,000	-111,961,000	-120,784,000	2,000,000	2,840,000	-20,362,000	4,216,000	44,766,000	-10,407,000	-53,261,000	-4,457,000
other long term liabilities																																			-217,000,000	-307,000,000	271,000,000	192,000,000	-50,000,000	-43,000,000	76,000,000	68,000,000
payment of long term debt																																			-1,819,000,000	-1,133,000,000	-1,736,000,000	-1,388,000,000	-673,000,000	-431,000,000	-226,000,000	-253,000,000
other current assets																																				-55,000,000	9,000,000	-35,000,000	7,000,000	-75,000,000	-25,000,000	-3,000,000	19,678,000	-53,504,000	25,415,000	3,411,000	-60,455,000	16,746,000	14,658,000	-50,537,000	-13,331,000	10,618,000	-23,382,000	-10,723,000	-5,145,000	-2,666,000	-2,365,000	-1,636,000	-308,000	-3,880,000	2,323,000	-1,375,000
debt issue costs																																				0	-8,000,000	-51,000,000	0	0	0	-4,000,000	-525,000	-456,000			-2,000	0	-2,926,000	-661,000					0	-147,000	-2,990,000	-6,105,000
proceeds from asset sale																																							0	0	0	7,000,000
proceeds from exercise of stock options																																							8,000,000	2,000,000	1,000,000	2,000,000	2,528,000	1,802,000	2,206,000	1,464,000	1,309,000	3,807,000	2,459,000	1,408,000	4,226,000	1,366,000	1,241,000	9,079,000	2,233,000	1,318,000	5,746,000	6,518,000	1,025,000	635,000	1,240,000	519,000
proceeds from stock offering																																															0	-14,000											0	0	-23,000	104,557,000
excess tax benefits from stock compensation																																							18,000,000	1,000,000	3,000,000	3,000,000	12,097,000	5,788,000	803,000	312,000	5,240,000	27,000	598,000	515,000	4,947,000	239,000	338,000	5,472,000	2,803,000	263,000	237,000	1,132,000	539,000	129,000	199,000	96,000
payment of contingent consideration obligation																																							0	-21,000,000	0	-8,000,000
gain on settlement of contingent consideration																																								-27,000,000	0	-10,000,000
health insurer fee paid
impairment loss																																																			0	0
gain on sale of investment in convertible note																																																			0
equity issued in connection with acquisition																																												58,041,000	0	132,371,000	0	-13,000
net decrease in cash and cash equivalents																																																	-42,079,000	-113,161,000												-53,663,000
gain on sale of investments																																																			-24,000				-74,000	-106,000	11,000	-118,000
gain on sale of uhp
proceeds from asset sales																																																											0	0	0	13,420,000
contribution from (to) noncontrolling interest
supplemental disclosure of non-cash investing and financing activities:
adjustments to reconcile net earnings to net cash from operating activities:
(gain) on sale of uhp																																																											0	0	0	-8,201,000
impairment loss on casenet, llc
changes in assets and liabilities:
medical claims liability
capital expenditures of centene center llc																																																							-708,000	-623,000	-2,227,000	-1,157,000
purchase of investments
investments in acquisitions, net of cash acquired, and investment in equity method investee
distributions from (to) noncontrolling interest
impairment of investment
contributions from (distributions to) noncontrolling interest																																																								325,000
distributions to noncontrolling interest																																																													-1,255,000	-3,585,000
(gain) loss on sale of investments																																																											-6,000	-2,344,000	-440,000	-3,547,000
distributions (to) from noncontrolling interest																																																											0
gain on sale of firstguard missouri
property acquired under capital lease obligation

We provide you with 20 years of cash flow statements for Centene stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Centene stock. Explore the full financial landscape of Centene stock with our expertly curated income statements.

The information provided in this report about Centene stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.